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family preventing them from activating the execution phase of apoptosis. Bcl-XL has been shown
to homodimerize in different ways, although most binding and structural assays have been carried
out in the absence of its carboxyl terminal transmembrane domain. We show here that this domain
can by itself direct protein oligomerization, which could be related to its previously reported role in
mitochondrial morphology alterations and apoptosis inhibition.
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Apoptosis is a type of cell death characterized by the silent elim-
ination of unnecessary or damaged cells, which is required for
development and tissue homeostasis. Two major routes of apopto-
sis have been described: the extrinsic route is initiated at the cell
surface and mediated by death receptors, like Fas-CD95 [1]; the
intrinsic route is mediated by mitochondria [2], where many differ-
ent signals are integrated and the ﬁnal decision about the fate of the
cell is made. Both routes are linked in some cells by Bid, a member
of the Bcl-2 protein family [3]. Bcl-2 familymembers participate di-
rectly in the decision step [4]. Pro-apoptoticmembers of this family,
Bax and Bak, have been shown to permeabilize the mitochondrial
outer membrane (MOM), facilitating the release to the cytosol ofon behalf of the Federation of Euro
d protein/mitochondrial car-
; IMS, intermembrane space;
ation; TMD, transmembrane
; VAMP2, vesicle-associated
ation and Physics of Complex
aragoza, C/ Mariano Esquillor
s).intermembrane space (IMS) proteins like cytochrome c [5], AIF [6]
or Smac/DIABLO [7,8]. These proteins then activate a series of cas-
pase-dependent or -independent mechanisms that dismantle the
cell. A second mechanism for the release of apoptotic factors from
the IMS involves permeability transition, which allows the entry
of water in the matrix with subsequent burst of the MOM [9].
A complex interplay between pro-apoptotic and pro-survival
Bcl-2 family members controls MOM permeabilization (MOMP),
considered the point-of-no-return during apoptosis induction. Sev-
eral models have been proposed to explain how Bcl-2 members
regulate MOMP through interactions between pro-survival and
pro-apoptotic proteins, both in solution and at the MOM [10]. Acti-
vation of these proteins involves conformational changes, specially
relevant for Bax, which usually resides in the cytosol and requires a
conformational change to expose hydrophobic domains required
for membrane insertion, followed by further changes necessary
for pore formation through oligomerization at the MOM [11].
Homodimerization of the pro-survival protein Bcl-XL in the
cytosol involves a C-terminal membrane-targeting a helix from
one monomer and a hydrophobic groove on the other monomer
[12], although other dimerization modes have been described
[13–16]. Release of that helix from the hydrophobic groove allows
its insertion into the MOM. Most interaction and structural studiespean Biochemical Societies.
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the C-terminal helix. This mutant can also bind membranes
through its N-terminal domain [17], and Bax, Bcl-2 and Bcl-XL have
been reported to insert a-helices 5 and 6 into the MOM during
apoptosis [18–20]. Many interaction and structural studies have
been carried out in the absence of membranes, underestimating
their role in protein interactions and conformational changes
[17,21].
Since the C-terminal helix (transmembrane domain or TMD) of
Bcl-XL and ﬂanking sequences contain the necessary information
for MOM targeting and insertion in a C-in N-out orientation [22],
we used this domain to target fragments of PSAP/Mtch1 to the out-
er mitochondrial membrane [23]. PSAP was ﬁrst identiﬁed as a
presenilin-1 associated protein with homology to inner membrane
mitochondrial carriers, and therefore is also known as mitochon-
drial carrier homolog 1 (Mtch1) [24]. The importance of its closest
homolog, Mtch2, in Bid-induced apoptosis has been reported re-
cently [25]. We reported that PSAP is a MOM protein with two
pro-apoptotic domains [23]. Since apoptosis induction by these do-
mains could depend on interactions with other proteins, we sought
to analyze PSAP interactions by crosslinking. These assays sug-
gested that the TMD of Bcl-XL could be involved in oligomeriza-
tion, which was conﬁrmed analyzing fusions to monomeric red
ﬂuorescent protein (mRFP).
2. Materials and methods
2.1. General reagents
All reagents were of molecular biology grade. Restriction
enzymes were from Roche, Stratagene, Invitrogen, Fermentas and
New England Biolabs; Accuprime Pfx DNA polymerase, custom-
made primers and T4 DNA Ligase were from Invitrogen; Pfu poly-
merase, from Stratagene.
2.2. Construction of expression vectors
Expression vectors containing PSAP or Mtch2 sequences have
been previously described [23]. pJAC295, expressing myc-mRFP-
TMD Bcl-XL (39.1 kDa), was constructed by amplifying the mRFP
sequence from another vector by PCR with primers containing
Eco RI (mRFPEcoF: 50-CTAGGATCGAATTCGGATGGCCTCCTCCGAG-
GACGT-30) and Hind III (mRFPHindR: 50-CTAGGATCAAGCTTGGC
GCCGGTGGAGTGGCGGC-30) restriction sites. The digested PCR
product was used to replace PSAP sequences in the vector express-
ing myc-PSAP65-112-Bcl (which contains the TMD of Bcl-XL) [23].
The resulting vector expresses mRFP preceded by a myc tag and
followed by the sequence KLESRKGQERFNRWFLTGMTVAGVVLL
GSLFSRK, where the ﬁrst two amino acids (kl) correspond to the
Hind III site and the remaining amino acids, to the TMD of Bcl-XL.
The same approach was used to construct vector pAOC2,
expressing myc-mRFP-TMD VAMP2 (32.2 kDa), replacing PSAP se-
quences in a vector that expresses myc-PSAP39-168-Vamp (which
contains the TMD of VAMP2) [23]. In this case, sequence
KLLKRKYWWKNLKMMIILGVICAIILIIIIVYFSS followed mRFP. pAL2
(28.7 kDa), expressing myc-mRFP, was constructed by digesting
pJAC295 with Hind III and Not I, to eliminate the TMD of Bcl-XL,
blunting with Pfu polymerase, and re-ligating. Vectors were trans-
formed into E. coli JM109 from Promega. Correct clones were con-
ﬁrmed by restriction digestion and sequencing. pAOC5, expressing
myc-Bcl-XL (full length Bcl-XL preceded by a myc tag, 28.6 kDa),
was constructed by carrying out a PCR on a vector containing the
cDNA for Bcl-XL with primers BCLXLECOF (50-CTAGGATCGAA
TTCGAATGTCTCAGAGCAACAACCGGGAGC-30) and BLCLXLNOTR
(50-CTAGGATCGCGGCCGCTCATTTCCGACTGAAGAGTGAG-30). The
PCR product was digested with Eco RI and Not I and inserted intopCMVMyc. pAOC6, expressing myc-BclXL-DTMD (Bcl-XL without
its carboxyl terminal transmembrane domain, preceded by a myc
tag, 26.7 kDa), was constructed by PCR with primers BCLXLECOF
and BCLXLWOTMXHOR (50-CTAGGATCCTCGAGGGCTGCTGCATT
GTTCCCATAG-30). The product was digested with Eco RI and Xho
I and cloned into pCMVMyc. pAOC7, expressing myc-BclXL-
TMD2Pit2 (BclXL preceded by a myc tag and with its carboxyl ter-
minal domain replaced by the second transmembrane domain of
Pit 2, 27.3 kDa) was constructed by doing PCR on vector pVLG60
(pEGFpN1-PSAP-DTM1-Pit2TM2, see Lamarca et al. [26]) with
primers Pit2TM2XhoF (50-CTAGGATCCTCGAGAGGCAGGCATGCA
TTTTAGCTTC-30) and Pit2TM2NotR (50-CATGGTACGCGGCCGC
TCATTTGGCGCCTAGTAACACGGAG), the product was digested with
Xho I and Not I and used to replace the equivalent fragment in vec-
tor pAOC6. The sequence of the second transmembrane domain of
Pit 2 (TMD2Pit2) used is RQACILASIFETTGSVLLGAK. pAOC8, which
expresses myc-BclXL-TMD3Pit2 (BclXL preceded by a myc tag and
with its carboxyl terminal domain replaced by the third transmem-
brane domain of Pit 2, 27.3 kDa), was generated by PCR with
primers Pit2TM3XhoF (50-CTAGGATCCTCGAGATGGCTGGGGAAGTT
AGTGC-30) and Pit2TM3NotR (50-CTAGGATCGCGGCCGCTCACAGG
AAGGAAGCAATCAGCT-30) in the same way as done with pAOC7,
but using vector pVLG61 (pEGFpN1-PSAP-DTMI-Pit2TM3, see
Lamarca et al. [26]) as template for the PCR. The sequence of the
third transmembrane domain of Pit2 (TMD3Pit2) used is
MAGEVSAMVGSAVWQLIASFL.
2.3. Cell culture and transfection
HEK293 cells and HeLa cells were cultured as previously
described [26] and transfected using GeneJuice Reagent (Novagen)
at a conﬂuence of 80% in 24-well plates.
2.4. Crosslinking and immunoblotting
12 h post-transfection, cells were washed twice with 500 ll
phosphate-buffered saline (PBS) and resuspended in 180 ll
crosslinking buffer (20 mM sodium phosphate, 150 mM NaCl, pH
7.5) containing 0.2 mM phenyl-methyl-sulfonyl-ﬂuoride (PMSF).
To detect de effect of expression of chimeras on Bax and Bak
oligomerization, 12 h post-transfection cells were treated with
30 lMcamptothecin for 24 h, and then processed as indicated. Sam-
pleswere divided in two tubes, 10 ll of a 25 mMsolution inDMSOof
the amine-reactive membrane-permeant crosslinker BSOCOES
(Bis[2-(succinimidooxycarbonyloxy)ethyl]sulfone) (Pierce) was
added to one tube and10 ll DMSOto the second tube, and incubated
for 1 h or 20 min (for Bax and Bak) at room temperature with agita-
tion. 5 ll quenching solution (1 M Tris Hcl, pH 7.5) was then added
and samples agitated for 15 min at room temperature. Cells were
recovered by centrifugation and analyzed using SDS–PAGE (Lae-
mmli) followed by immunoblotting with anti-myc (Invitrogen),
anti-PSAP MGAS [26], anti-Bax (Millipore) or anti-Bak (Millipore)
antibodies after transfer onto polyvinylidene ﬂuoride (PVDF) mem-
branes (Invitrogen), as described [23]. Proteins were visualized by
incubation with goat-anti mouse or goat anti-rabbit secondary
antibodies conjugated to HRP and detected by ECL. Molecular mass
markers were from Invitrogen (BenchMark Pre-Stained Protein
Ladder) or Bio-Rad (Precision Plus Protein Standards).
2.5. Blue-native electrophoresis (BN-PAGE)
BN-PAGE was carried out with digitonin-treated cells using the
NativePAGE™ Novex Bis–Tris Gel System from Invitrogen, 4–16%
gradient gels, following instructions supplied by the manufacturer.
10 lg protein was loaded per well. Native protein standards were
from Invitrogen (NativeMark Unstained Protein Standard).
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We used the Cell Proliferation Kit II (XTT) (Roche) as a quick
method to measure cell death induced by camptothecin. HEK293
cells were cultured and transfected in 96-well plates, 12 h post-
transfection cells were treated with 30 lM camptothecin or DMSO
and 24 h later they were incubated with XTT. Two independent
assays were carried out in triplicate.
For trypan blue exclusion assays, HEK293 cells were cultured in
24-well plates until they reached 80% conﬂuency and then trans-
fected and treated with camptothecin or DMSO as indicated above.
24 h post-transfection wells were washed with PBS, which was
transferred to tubes to avoid loosing detached cells. Attached cells
were trypsinized for 5 min and mixed with detached cells in PBS
from the same well. Complete media, with serum, was added to
inactivate trypsin. Cells were mixed with trypan blue (Roche) in
a 1:1 ratio and counted using a hemacytometer. For each sample,
four quadrants were scored twice, with cell numbers rangingFig. 1. Crosslinking of PSAP chimeras. Western blot of crosslinker-treated cells (+)
or untreated () expressing PSAP1-168-TMD Bcl-XL or PSAP1-168-TMD VAMP2,
separated on a 10% SDS gel and detected with anti-MGAS. Sizes of molecular mass
markers are indicated on the left. Bands likely corresponding to heterodimers of
PSAP1-168-TMD VAMP2 with endogenous VAMP2 are indicated with an asterisk on
the right.
Fig. 2. Crosslinking of PSAP and Mtch2 chimeras. Western blot of crosslinker-
treated cells (+) or untreated (-) expressing myc-PSAP-65-112-TMD Bcl-XL or myc-
Mtch2-1-90-TMD Bcl-XL, separated on a 10% SDS gel and detected with anti-myc.
Sizes of molecular mass markers are indicated on the left.between 18 and 35 per quadrant. For one of the experiments an
automatic cell counter (Countess from Invitrogen) was used,
obtaining similar results as with manual counts. Each experiment
was carried out in triplicates three independent times.
2.7. Immunocytochemistry
For subcellular localization of Bcl-XL chimeras, cells grown on
round coverslides in 24-well plates were ﬁrst incubated with 25
nM Mitotracker Red CMX-Ros (Invitrogen) for 30 min at 37 C, the
culture media replaced with fresh media and incubated again for
30 min at 37 C. Cells were then ﬁxed with a solution containing
50% culture media and 50% of a 3.7% formaldehyde solution inFig. 3. Crosslinking and blue-native electrophoresis of mRFP chimeras. (A) Western
blot of crosslinker-treated (+) or untreated () cells expressing myc-mRFP-TM Bcl-
XL, myc-mRFP-TMD VAMP2 or myc-mRFP alone, separated on a 10% SDS gel and
detected with anti-myc. Sizes of molecular mass markers are indicated on the left.
Bands corresponding to dimers (63.7 and 64.4 kDa) are indicated with an asterisk
on the right. (B) Blue-native electrophoresis analysis of mRFP chimeras. Digitonin-
solubilized proteins from cells expressing myc-mRFP-TMD Bcl-XL, myc-mRFP-TMD
VAMP2 or myc-mRFP alone were separated on native 4–16% gradient gels, blotted
and detected with anti-myc. Sizes of native molecular mass markers are indicated
on the left.
Fig. 4. Subcellular localization of mRFP and Bcl-XL chimeras. (A) HeLa cells were grown on round coverslips, transfected with vectors encoding myc-mRFP-TMD Bcl-XL, myc-
mRFP-TMD VAMP2 or myc-mRFP, incubated with Mitotracker green, ﬁxed with formaldehyde and mounted for microscopy. (B) HeLa cells grown as in A and transfected with
myc-BclXL, myc-BclXL-DTM, myc-BclXL-TMD2Pit or myc-BclXL-TMD3Pit, incubated with Mitotracker red CMX-Ros, with an anti-myc antibody, with goat anti-mouse Alexa
ﬂuor 488-conjugated antibody and mounted for microscopy. Images were acquired with a Leica DMI6000B inverted ﬂuorescence microscope using structured illumination
(Optigrid) with ﬁlters suitable for mRFP/Mitotracker Red and for Mitotracker green/Alexa ﬂuor 488, and overlayed to show co-localization using software Metamorph. Bar is
10 lm.
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hyde solution in PBS, and then blocked and permeabilized with a
solution containing 1% BSA and 0.1% TX-100 in PBS for 1 h. After
three 10-min washes with PBS, cells were incubated with an anti-
myc antibody from Invitrogen at a 1:700 dilution for 2 h, washed
with PBS and incubated with an Alexa Fluor 488-conjugated goat
anti-mouse secondary antibody (Molecular Probes) for 1 h, washed
again with PBS and mounted for microscopy using Fluoromount G
(Sourthernbiotech).
Subcellular localization of mRFP chimeras was carried out as for
Bcl-XL chimeras but using 100 nM Mitotracker Green.
2.8. Microscopy
We used a Leica DMI6000B inverted ﬂuorescence microscope
with structured illumination (Optigrid) and software Metamorph.
For red ﬂuorescent protein and Mitotracker red we used a BP560/
40 excitation ﬁlter and a BP645/75 emission ﬁlter with a 595 nm
dicroic, and for Mitotracker green and Alexa Fluor 488, we used a
ﬁlter for GFP, excitation BP470/40, emission BP525/50 and
500 nm dicroic.
3. Results
In order to study PSAP function we generated several deletion
mutants which were used to study mitochondrial import and
induction of apoptosis by this protein [23]. We targeted PSAP frag-
ments to the MOM by fusion to the TMD of Bcl-XL, demonstrating
that MOM localization was required for apoptosis induction, since
endoplasmic reticulum-targeting by fusion to the TMD of VAMP2
[27] did not induce apoptosis.
Since apoptosis induction by PSAP could bemediated by interac-
tions with other proteins, we attempted to detect PSAP-interactingproteins by crosslinking, using some of the above-mentioned chi-
meras.WhenHEK293 cells expressing the ﬁrst 168 residues of PSAP
fused to the TMD of Bcl-XL (PSAP1–168TMD Bcl-XL, 21 kDa) were
treated with BSOCOES, a band was observed by western blot sug-
gesting dimerization of the protein (Fig. 1, lane 2). Similar results
were obtained with the protein containing the TMD of VAMP2
(PSAP1–168TMD VAMP2, 21.2 kDa). Since both proteins share the
same PSAP sequences, we ﬁrst assumed that PSAP was mediating
dimerization. Nevertheless, a literature search indicated that the
TMD of VAMP2 is responsible for its homo or heteromerization at
the ER membrane [28], suggesting that the dimers observed in
our experiments could depend on TMD instead of PSAP sequences.
This interpretation could also explain a band migrating between
those corresponding to the monomer (21.2 kDa) and dimer
(42.4 kDa) in lanes 3 and 4 of Fig. 1, as a heterodimer between
endogenous VAMP2 (12.6 kDa) and PSAP1–168TMD VAMP2
(expected molecular mass: 33.8 kDa, marked with an asterisk in
Fig. 1). Note that some of the bands are also present in the absence
of crosslinker, suggesting strong interactions.
When similar constructs containing shorter PSAP fragments
were used, oligomerization was observed. Fig. 2 shows the results
obtained with a construct containing residues 65–112 preceded by
a myc tag and followed by the TMD of Bcl-XL (11.2 kDa). Crosslink-
ing of a protein chimera containing Mtch2 sequences (16 kDa)
instead of PSAP sequences (lanes 3 and 4 in Fig. 2) also produced
oligomers.
Our constructs contained parts of PSAP or Mtch2 and the TMD
of Bcl-XL, proteins that can all be inserted into the MOM, therefore
we could not rule out a mixed effect due to different sequences
from either protein. In fact, whether dimers or oligomers were
observed depended on the sequences attached to the TMD (Fig. 1
and Fig. 2). In order to clarify this subject, we fused the TMD of
Bcl-XL or that of VAMP2 to monomeric red ﬂuorescent protein
Fig. 4 (continued)
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(28.7 kDa) as control. Crosslinking assays indicated that similar
complexes could be detected when each TMD was fused to mRFP
(Fig. 3A), whereas myc-mRFP remained as a monomer, therefore
indicating that the TMDs were responsible for the dimers observed.
The contribution of PSAP sequences to dimers and oligomers
shown in Fig. 1 and 2 is under investigation and will be reported
elsewhere.
In order to analyze these interactions with a different
technique, we used blue-native electrophoresis (Fig. 3B), conﬁrm-
ing that fusion of mRFP to either the TMD of Bcl-XL or the TMD
of VAMP2 induced oligomerization of the protein. The pattern
obtained indicated the presence of oligomers up to pentamers,
although less abundant (or less stable) than the dimers. These data
clearly indicate the involvement of the TMD of Bcl-XL in self-
association, an event that had not been reported previously. The
fact that only dimers could be observed upon crosslinking could
be due to the location of the reacting amino groups in the oligo-
mers. Crosslinking covalently ﬁxes those interactions where react-
ing groups (amino groups in this case) are localized in close
proximity, and uncrosslinked molecules are separated later during
denaturing electrophoresis. Blue native electrophoresis does not
rely on speciﬁc reactive groups but on the overall stability of
protein complexes where individual molecules are held together
by non-covalent bonds. It could be that, in our complexes, reacting
amino groups are only located closely between monomers of asingle dimer, and dimers associate in oligomers in such a way that
adjacent dimers cannot be crosslinked with each other. This could
explain why dimers are mainly observed upon crosslinking
whereas oligomers are observed after blue-native electrophoresis.
We analyzed the subcellular localization of our chimeras by
ﬂuorescence microscopy, using Mitotracker green to label mito-
chondria. As expected, mRFP-TMD Bcl-XL localized to mitochon-
dria, mRFP-TMD VAMP2 localized to membranes and mRFP
distributed evenly throughout the cell (Fig. 4A).
The TMD of Bcl-XL fused to yellow ﬂuorescent protein has been
reported to alter mitochondrial morphology and to moderately
protect cells against staurosporine-induced apoptosis [29]. In order
to ﬁnd out if our mRFP-TMD Bcl-XL chimera also protected cells
against camptothecin-induced cell death we carried out cell viabil-
ity assays using XTT, which were later conﬁrmed by trypan blue
exclusion assays. The results, shown in Fig 5, clearly indicated that
the TMD of Bcl-XL fused to mRFP protected cells from death,
whereas the TMD of VAMP2 fused to mRFP or mRFP alone did not.
Since Bcl-XL can prevent Bax and Bak oligomerization, we
analyzed the state of oligomerization of these two proapoptotic
proteins upon transfection of cells with mRFP chimeras and induc-
tion of apoptosis with camptothecin. We did not see any effect on
Bax and Bak oligomerization in cells transfected with either mRFP-
TMD Bcl-XL, mRFP-TMD VAMP2 or mRFP alone (Fig 6).
Even though Bcl-XL is able to dimerize in absence of its TMD
under some conditions, we analyzed how the absence of its TMD
Fig. 5. Protection of mRFP-TMD Bcl-XL against camptothecin-induced cell death.
HEK293 cells transfected with myc-mRFP-TMD Bcl-XL, myc-mRFP-TMD VAMP2 or
myc-mRFP alone were treated with DMSO or with 30 lM camptothecin for 24 h
starting 12 h post-transfection. (A) Cells were analyzed using the Cell Proliferation
Kit II (XTT) (Roche). Results of two independent assays carried out in triplicates are
shown. (B) Cells were analyzed by trypan blue exclusion. Results of three
independent assays carried out in triplicates are shown. Error bars indicate
standard deviation.
Fig. 6. Effect of overexpression of chimeras in Bax and Bak oligomerization. HEK293
cells were transfected with vectors encoding myc-mRFP-TMD Bcl-XL, myc-mRFP-
TMD VAMP2 or myc-mRFP, treated with 30 lM camptothecin for 24 h and the
effect on Bax and Bak oligomerization analyzed by crosslinking with BSOCOES.
Fractions from each sample were analyzed by western blot using antibodies against
Bax, Bak or myc (to detect overexpressed proteins). Sizes of molecular mass
markers run alongside are indicated on the left in kDa. , without BSOCOES; +, with
BSOCOES.
Fig. 7. Effect of different TMDs in Bcl-XL dimerization. Full length Bcl-XL (Bcl-XL),
Bcl-XL without its carboxyl terminal TMD (Bcl-XL DTMD), Bcl-XL with the second
TMD of Pit 2 (Bcl-XL TMD2Pit) or Bcl-XL with the third TMD of Pit 2 (Bcl-XL
TMD3Pit) all preceded by a myc tag, were overexpressed in HEK293 cells, treated
with the crosslinker BSOCOES and analyzed by western blot with an anti-myc
antibody. , without BSOCOES; +, with BSOCOES.
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dimerization. For this, we constructed a new vector to express
Bcl-XL without its TMD, as well as another vector encoding
Bcl-XL with its TMD replaced by the second TMD of Pit 2, a plasma
membrane sodium transporter [30]. We expressed these con-
structs in cells and carried out crosslinking assays using BSOCOES.
Under these conditions, we could detect dimers of full-length
Bcl-XL (Fig 7, lane 2) and no dimers of Bcl-XL lacking its TMD
(Fig 7, lane 4). Curiously, Bcl-XL with its TMD replaced by the
second TMD of Pit2 was also able to dimerize (Fig 7, lane 6).
Analysis of the sequences of the TMD of Bcl-XL and the sec-
ond TMD of Pit 2 revealed the presence of the sequence motif
GXXXXG (where G is glycine and X, any amino acid), in tandem
in Bcl-XL (GMTVAGVVLLG) and alone in the TMD of Pit2
(GSVLLG). Note that ﬁve out of six amino acids are conserved be-
tween sequence GVVLLG in Bcl-Xl and sequence GSVLLG in the
second TMD of Pit2. Since the sequence motif GXXXG had been
reported to be involved in dimerization of the BH3-only Bcl-2
family member BNIP3 through its TMD, and also in other pro-
teins [31–38], which is very similar to the motifs found in the
TMD of Bcl-XL and the second TMD of Pit2, we constructed a
new vector where the TMD of Bcl-XL was replaced by the third
TMD of Pit2, which lacks sequence GXXXXG. Crosslinking assays
with this new chimera indicated that it was unable to dimerize
(Fig 7, lane 8).
We analyzed the subcellular localization of these chimeras, with
myc-BclXL localizing to mitochondria as expected and the remain-
ing chimeras showing a diffuse localization in the cell (Fig 4B). This
also indicates that sequences involved in dimerization and mito-
chondrial targeting within the TMD of Bcl-XL are different, sincethe second TMD of Pit2 is able to induce oligomerization but not
mitochondrial localization.
4. Discussion
We have shown that the transmembrane C-terminal domain of
Bcl-XL can directly participate in oligomerization. This is a mode of
self-association unreported for Bcl-XL. Bcl-2 family members con-
trol their activities through a complex network of protein-protein
interactions, posttranslational modiﬁcations, transcriptional con-
trol or protein degradation [11]. Conformational changes induced
upon heteromeric or homomeric protein interactions are very
important for their activities.
Bcl-XL has been shown to dimerize by different mechanisms
under several conditions [12–17]. Many of these studies, as well
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TMD under non-physiological assay conditions, although its pres-
ence is likely to affect the overall fold of the protein, conforma-
tional changes and protein interactions.
Bcl-XL has been reported to regulate apoptosis by heterodimer-
ization-dependent and -independent mechanisms. The former
implies binding to pro-apoptotic proteins; the latter, could depend,
at least in part, on the formation of an ion channel that can coun-
teract the effects of MOM permeabilization by proteins like Bax or
Bak [39]. Interestingly, C-terminal cleavage products of Bcl-XL can
form a pore large enough to allow cytochrome c release [40],
changing a pro-survival protein into a pro-apoptotic one, what
has been also described for Bcl-2 upon binding of a Nur77-derived
peptide [41]. Zheng et al. [29] reported changes in mitochondrial
morphology and protection against apoptosis mediated by a
YFP-TM Bcl-XL fusion protein, suggesting that this TMD could be
required for a bioenergetic function of Bcl-XL distinct from BH3
domain sequestration. Our results suggest that oligomerization
mediated by the TMD of Bcl-XL could be involved in these
activities.
The TM domains of other Bcl-2 family members have been also
reported to be involved in protein dimerization, like the TMD of
BH3-only protein BNIP3 [37] or the TMD of Bax [42]. In the case
of BNIP3, the sequence GXXXG has been shown to directly partic-
ipate in dimerization. Interestingly, a similar sequence is present in
the TMD of Bcl-XL, but in tandem (GMTVAGVVLLG: GMTVAG and
GVVLLG), with one more amino acid between the two glycines
(GXXXXG). The presence of sequence GXXXG in tandem had been
previously described in other proteins [35,38]. Curiously, a very
similar sequence containing that motif is also present in the second
TMD of Pit2 (GSVLLG), which we used to replace the TMD of BclXL
expecting to block dimerization (before we analyzed the TMD
sequences), and Bcl-XL with that TMD also dimerizes. BclXL with
its TMD replaced by the third TMD of Pit2, which does not contain
that sequence motif, does not dimerize, strongly suggesting the
importance of motif GXXXXG in dimerization.
Sequence GXXXG was ﬁrst reported to be involved in TMD
dimerization by Engelman and coworkers [34,43]. Furthermore,
within these motifs, residues V and L are also usually present close
to G residues, as is the case for the TMD of Bcl-XL and the second
TMD of Pit2. Sequence speciﬁcity in the dimerization of transmem-
brane alpha-helices was ﬁrst reported by Lemmon et al. [31],
reporting later that the pattern LIxxGVxxGVxxT is involved in
dimerization [44]. Furthermore, the GXXXG motif has been in-
volved in the formation of a membrane channel by the Helicobacter
pylori vacuolating toxin [38], where this motif appears in three
tandem repeats. This motif has also been found in several other
proteins, like subunits e [45] and g [46] of yeast mitochondrial
ATP synthase, APH-1 [47], ABCG2 [48], the SARS coronavirus spike
protein (were it is involved in trimerization) [49], prion protein
[50], amyloid precursor protein [51], the two-peptide bacteriocin
lactococcin G [52], carnitine palmitoyltransferase 1A [53], ErbB
[54], protein FliH and its Type III secretion homologue YscL [55],
the Japanese encephalitis virus precursor membrane (prM)
protein [56], the PufX polypeptide of Rhodobacter sphaeroides
RC-LH1 photosynthetic complex [57], human organic anion trans-
porter 1 (hOAT1) [58], VDAC1 [59] and the NS4B protein of hepati-
tis c virus [60]. A review about some of these proteins can be seen in
Senes et al. [61].
Although in the TMD of Bcl-XL the two glycines are separated
by four residues instead of 3 as in the GXXXG motif, our results
strongly suggest that this motif is mediating interaction of Bcl-XL
molecules through their TMDs, since the second TMD of Pit2, with
5 out of 6 conserved residues within that GXXXXG motif also al-
lows dimerization of the protein, whereas the third TMD of Pit2,
which lacks that motif, does not dimerize when fused to Bcl-XL.In summary, we have shown that the TMD of Bcl-XL is involved
in protein dimerization and that motif GXXXXG is very likely
responsible for this interaction. This will most likely have impor-
tant implications in Bcl-XL function.Acknowledgements
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